Identification of HDAC9 as a viable therapeutic target for the treatment of gastric cancer

Global cancer statistics

Ahmedin Jemal, Freddie Bray · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text

Global cancer statistics, 2012

Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.2K citations · Full text

FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma

Bhupinder Mann, John R. Johnson, Martin H. Cohen et al. · The Oncologist · 2007 · 1.3K citations · Full text

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Yoon‐Koo Kang, Won Ki Kang, D.B. Shin et al. · Annals of Oncology · 2009 · 773 citations · Full text

First-line Therapy, Surgical Oncology, Gastrointestinal Oncology +7

Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis

Wilko Weichert, A.-E. Roske, Volker Gekeler et al. · The Lancet Oncology · 2008 · 362 citations

Histone Modifications, Chromatin, Gastrointestinal Oncology +12